News from

Coronavirus Research

Reset All Filters
445 Results
With few new clotting cases, Johnson & Johnson pause could be lifted soon
The New York Times

With few new clotting cases, Johnson & Johnson pause could be lifted soon

Ezekiel J. Emanuel, a professor of medical ethics and health policy, says that the benefits of more available vaccines outweighs the possible risks the J&J shot may have on the population. “It’s just very hard for me to see, even if you multiply the number of cases by five or by 10, that you come to the conclusion that this is not a good thing to do, giving you the vaccine.”

Study suggests those who had COVID-19 may only need one vaccine dose
medical professional in scrubs holds a vial of covid vaccine.

Image: Dan Burke

Study suggests those who had COVID-19 may only need one vaccine dose

People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, therefore only a single dose may be needed to produce a sufficient antibody response, according to new research from the Penn Institute of Immunology.
In the U.S., COVID-19 wasn’t sole cause of excess deaths in 2020
A hospital room with all lights off but the fluorescent light above bed, which has a green blanket. Behind the bed is a hospital tray that swivels and a blue chair. On the yellow wall behind are about 8 outlets.

In the U.S., COVID-19 wasn’t sole cause of excess deaths in 2020

Comparing death rates in the United States with those of the five biggest European countries, Penn and Max Planck demographers found that significant excess mortality cost more lives annually than the epidemic itself.

Michele W. Berger

Regeneron to seek U.S. OK for COVID-19 cocktail to be used for prevention
Reuters

Regeneron to seek U.S. OK for COVID-19 cocktail to be used for prevention

Katharine Bar of the Perelman School of Medicine spoke about her research on the efficacy of a new preventative treatment for people in households where someone has contracted COVID-19. “These data pave the way for REGEN-COV to be used before patients become symptomatic,” she said.

Kati Kariko helped shield the world from the coronavirus
The New York Times

Kati Kariko helped shield the world from the coronavirus

Katalin Kariko, who worked with colleague Drew Weissman in the Perelman School of Medicine to research mRNA, was profiled. Their findings laid the foundation for the development of the Pfizer and Moderna COVID-19 vaccines.

Pa. coronavirus update: North Philly to get vaccination site; Study finds variants spread in city
WHYY (Philadelphia)

Pa. coronavirus update: North Philly to get vaccination site; Study finds variants spread in city

Frederic Bushman of the Perelman School of Medicine spoke about a recent study that found that more than one-third of Philadelphia COVID-19 infections were caused by variants of the virus. “The fear is that the virus is evolving to infect people more efficiently,” he said.